fibrosis also seen. Portal hypertension is a significant complication of cirrhosis and is responsible for development of esophageal varices. 1 Early detection of varices is important for treatment and prevention of progression. Over the last decade, it has become the common practice to screen known cirrhotics with endoscopy to look for esophageal varices. Several factors predict the risk of bleeding, including the severity of cirrhosis (Child's class, MELD score), the height wedged hepatic vein pressure, the size of varices, and some endoscopic stigmata, including red wale signs, haematocystic spots, diffuse erythema, bluish colour, cherry red spots or white nipple spots. 2 There is no reliable noninvasive predictor for the presence or absence of esophageal varices that can be adopted in clinical practice. Various study show that transient elastogram and APRI for the assessment of oesophagealvarices in cirrhotic patient has a excellent accuracy. 3 The parameter is chosen as it allows us to assess velocity of ultrasound wave through the fibrosed liver and another parameter like simple blood test aspartate aminotransferase and platelet count are easily obtainable and noninvasive and can be done as a routine liver function test. So, considering these results can be very helpful in predicting the esophageal varices. 4 In our country most of the patients with cirrhosis present at advanced decompensated stage. Endoscopic
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evaluation for esophageal varices is not always possible at most of the health care centers. Though endoscopy is gold standard to find varices, in order to relieve the patients from discomfort and the risk of rupture during endoscopy and to reduce costs, efforts to find non invasive methods like transient elastography and Aspartate aminotransferase-to-Platelet ratio index (APRI) are thought to be promising.
About 80% of patients with cirrhosis of liver will eventually develop varices. 5 In cirrhotic patients who do not have esophageal varices at initial endoscopy, new varices will develop at a rate of approximately 5% per year. Up to 25% of patients with newly diagnosed varices will experience variceal bleeding within two years. 1 In patients with cirrhosis who are being followed chronically, the development of portal hypertension is usually revealed by the presence of thrombocytopenia, the appearance of an enlarged spleen, or the development of ascites, and/or esophageal varices with or without bleeding. 2 Endoscopy is the only means to directly visualize varices which are a consequence of portral hypertension. 6 The predisposing factors of bleeding are large size of the varices, endoscopic variceal features such as red spots and stripes, high portal pressure and liver failure. Drugs capable of causing mucosal erosion, such as salicylates and NSAIDs can also precipitate bleeding. 7 Current practice guidelines recommended endoscopic screening for the presence of esophageal varices in all patients with cirrhosis. If varices are not present, screening endoscopy should be repeated 2-3 years or sooner if there is evidence of hepatic decompensation. 5 Other methods for detection of varices are ultrasonogram with Doppler study, CT scan, Gadolium-enhanced MRI and endosonography 1 
.
Several studies have recently attempted to identify non-invasive predictors of esophageal varices. They are platelet count, AST-to-ALT ratio, AST-to-platelet ratio index (APRI),Platelet count/ spleen diameter ratio, Lok index, Forns' index, Fib-4 and fibroindex. Of these Transient elastogram, APRI, and Platelet count/spleen ratio are promising predictors. 8 It was suggested that liver stiffness measured by transient elastography, a novel non-invasive technology may reflect not only fibrosis and portal pressure but it may even predict the presence or absence of large esophageal varices, in patient with cirrhosis. Liver stiffness values significantly correlates with the grade of esophagealvarices.The liver stiffness value of 19.2 kPa was highly predictive for the presence of esophageal varices 6 .
Ultrasound elastography offers a number of advantages. It is easy to use and inexpensive. The acquisition speed is very high(less than one tenth of a second peracquisition) and, therefore the acquisitions are not biased by cardiac and respiratory movements. Once the probe is positioned correctly, the measurement is fully automated and independent from the operator. 9 Aspartate aminotransferase to platelet ratio index (APRI) was first described for the non-invasive predictor of fibrosis which is the major cause of portal hepertension in cirrhosis and platelet count on its dominator, a variable knowingly associated with the presence of esophageal varices. Patients with an index lower than this cut off were supposed not to have esophageal varices. APRI at a cut off 1.3 was used to predict the existence of oesophageal varices. 10 Platelet count/spleen diameter ratio as measured by abdominal ultrasound could be an accurate predictor of esophageal varices.In patients with compensated cirrhosis, the higher the ratio, the less likely it is that a patient will have varices. During the course of cirrhosis repeated course of endoscopy is recommended. As this intervention is expensive and often poorly accepted by patients who may refuse further follow up, there is a need for non-invasive methods to predicts the progression of portal hypertension as well as the presence and size of esophageal varices. 6 This study was aimed to assess the liver stiffness values by transient elastography for predicting esophageal varices in cirrhotic patients and to assess the value of APRI for predicting esophageal varices in cirrhotic patients.
Materials and methods
This study was an observational cross sectional study carried out at the department of Gastrointestinal, Hepatobiliary and Pancreatic Disorders (GHPD), BIRDEM General Hospital, Dhaka, Bangladesh during the period of August 2015 to October 2016. Adult patients age ≥18 years who are suffering from cirrhosis irrespective of cause were included and the following type of patients were excluded from this study: Patient having active gastrointestinal bleeding at the time of admission, those who had known severe co-morbid disease, known case of hematological malignancy or bleeding disorders, patient who was morbidly obese and tense ascites and CLD patient who had history of variceal band ligation or sclerotheraphy. Demographic and clinical variables were age, sex,etiology of cirrhosis of liver, jaundice, ascites, hepatic encephalopathy, edema, spider, testicular atrophy, gynaecomastia. Laboratory variables were haemoglobin level, serum albumin, serum billirubin, AST, ALT, Prothrombin time, platelet count, Endoscopic variceal grade,Transient elastography score.
Endoscopy of upper GIT were done by Olympus GIF-Q 160 video endoscopy in endoscopy room in presence and under direct supervision of the thesis guide and co guide. Varices were classified into small medium & large by WGO practice guideline grading system. Liver stiffness status was performed via transient elastography. All reading are taken from right lobe of liver with patient lying at supine position and with right arm in full abduction, An appropriate site for liver stiffness acquisition was identified in the mid axillary line using ultrasound probe. The median value of 10 successful acquisition, express in kPa, was kept as representative of the liver stiffness. [16] [17] [18] [19] [20] [21] After collection of information these data, checked, verified for consistency & edited for finalized result. After editing & coding, the coded data entered into the computer by using the SPSS (Statistical Package for Social Sciences) version-22.0 software. Data cleaning validation &analysis performed using the SPSS software. Statistical analyses by using appropriate statistical tool like t-test and chi square test. The results were presented in tables in mean, standard deviation (SD) & percentages. Statistical significance set at 0.05 level and confidence interval at 95% level. Ethical clearance was taken from the ethical review committee of Birdem General hospital (BADAS).
Results:
Total 65 patients with cirrhosis were enrolled in this study. Subjects of the study was male dominant. Abdominal distension was more common. Anaemia, Leukonychia, oedema and spider were frequently present. Figure 1 shows the aetiology of liver cirrhosis. Most of the patients were non B and non C related. ROC curve shows test accurateness (Figure 2 ) of APRI for the prediction of esophageal varices (AUC=0.779 and p = 0.003) This observational study was carried out with an aim to assess the liver stiffness value and aspartate aminotransferase (AST) with platelet count & determine the state of esophageal varices by endoscopic evaluation. Finally our aim was to evaluate the relationship Liver stiffness value with esophageal varices & APRI with varices in cirrhotic patient.
Fig1
Fig 2
In this study, 65 patient was diagnosed as a cirrhosis. It was observed that cirrhosis were predominant at fifth decade 18 (27.7%). The mean age of presentation (53.8%) (table-1). Among them 43(66.2%) were male & 22(33.8%) were female (table 1) . In a study, Mattos found the mean age of cirrhosis is 56.7 years and male are predominant 59.7%. 10 The mean age and sex differences of above study correlate with our study.
Regarding clinical variables it was observed that 20 (30.8%) had abdominal distension or swelling, 11(16.9%) had hematemesis, 9(13.8%) had melena, 8(12.3%) had jaundice and 7(10.8%) had hepatic encephalopathy. Spider angioma and Gynaecomastia were observed in 30(46.2%) and 13(20%) respectively. On abdominal examination Hepatomegaly, splenomegaly, ascites, testicular atrophy were found in 6(9.2%), 29(44.6%), 23(35.4%) & 21(26.2%) respectively. (table 1) ; Fraqueli observed 20% had jaundice, 20 % hematemesis, spenomegaly 35.7%, and these observations are comparable with the current study. 14 In our study, patient with EVs had lower platelet count (mean±SD 101.01± 37.74 10 9 /L) than those without EVs (mean±SD 131.54±46.4x10 9 /L). This difference was statistically significant (p<0.035) among the groups. (Table  2 ). Sebastini found that the platelet count was lower in patient with esophageal varices (mean±SD, 98.8±48.4 x10 9 /L ) than patient without cirrhosis (mean±SD, 142.8±70.1 x10 9 /L) which is almost similar to our results. 8 Chalasani reported that platelet count can predict the significant esophageal varices. 15 Our study showed Hepatitis B virus (HBV) was 30.8%, Heptitis C virus was (HCV) 15.4% and other causes was 53.8% ( Figure 1 ). Sebastini showed, HCV 55.1%, alcohol 30.4%, HBV 8.% & others were 36.1% which differs from our study probably due to prevalence of HCV, HBV and alcoholism are more in western countries and most patients of our study in were tertiary diabetic care hospital had diabetic related fatty liver disease which leads to CLD. 8 APRI by its two component AST & Platelet has different cut off value for its sensitivity and specificity, Positive predictive value (PPV), negative predictive value (NPV) vary. In this study, when APRI at cut off 1.00 was used in order to predict the existence of EVs, it was found moderate sensitivity 63.3% (95% CI=55.6-65.4), a specificity 83.3% (95%CI=53.7-97.0), PPV 94.3% (CI=84.1-99.0), but NPV 33.3% (95% CI=21.5-38.8). Other cut off points were also tested, but none of them could reach a significantly better negative predictive value (table 3) . Mattos showed at cut of value 1.3 a sensitivity 64.7% (0.56-0.86), specificity 72.7% (CI=0.59-0.86), PPV of 86.5% (CI=0.79-0.94), NPV of 43.2% (CL=0.32-0.55) which is almost similar to our study. 10 Castera proposed the cutoff of 1.3 for APRI as a predictor of EV, where they found sensitivity 68%, specificity 64%, PPV 51%, NPP 78%, which is dissimilar from our study. 16 That study was only on hepatitis C positive patient & Child A grade were included. In our study all etiologies & all grade including compensated and decompensated cirrhosis were included. Tafarel studied at a higher cut of point (1.64) and found it is significant. Here in this study higher cutoff value also tested, though good specificity and positive predictive value were found, sensitivity and NPV were disappointing. 17 Wang proposed lower cut of value 0.77 as the optimal one to predict EVs with a better sensitivity 71% & NPV 79%, but in our study in lower value, specificity & NPV were disappointing. 18 In current study the diagnostic performance of Transient elastography (TE) was tested, as a noninvasive tool for prediction of EV (Table 4 ). There were different cutoff values for their prediction. In this study, if liver stiffness value cutoff point is 18 Kpa, sensitivity 88.7% (95% CI 82.7-92.7), specificity 75.0% (95% CI 46.9-92.6). PPV 94%, NPV 60.0%. AUROC = 0.769, P =0.004 were observed indicating moderately high level of significance (Figure 4 ). Hassan showed that TE could diagnose the EV at a cutoff value of 18.2 Kpa. Its sensitivity 80%, specificity 72%, PPV 84%, & NPV 67%. 19 This was almost similar to our study. Liu showed cutoff value at 18 with 91% sensitivity & 63% specificity which comparable to our study. 20 Kitson showed the higher cutoff value of 25Kpa to predict EVs with a sensitivity 71.9%, specificity 58.1%, PPV 88%, NPV 88% which is dissimilar to our study. 11 At higher cutoff value in our study NPN in 32 which was not significant. Fraquelli also showed similar result which correlates with our study. 14 Qu show a meta-analysis with a good sensitivity 84%, specificity 68%, positive likelihood ratio 2.58, and negative likelihood ratio 0.24, which is also comparable to our study. 21 The transient elastography and APRI has also been examined by many authours in many countries and different cutoff of value was proposed but lack the generalized consistent results. In our study transient elastography can predict the EVs but APRI did not perform better for detection of EVs.
This study had several limitations, as the study population was selected from one hospital in Dhaka city, so that the results of the study may not reflect the exact picture of the country, Sample size was small, and grading of varices may be subject to inter-observer variability.
In conclusion, the identification of non-endoscopic and non-invasive methods that can accurately predict EVs in cirrhosis of liver has been addressed in recent years. There was a significant positive correlation found between transient elastography and EVs in cirrhotic patients. Liver stiffness value of 18 Kpa can predict EVs in cirrhotic patients and a useful adjunct for clinicians in the management of cirrhotic patients But APRI had a wide range of cut of points that proves there is no satisfactory cutoff value for APRI to be used as a predictor of EVs. Variceal bleeding is a serious complication of cirrhosis; APRI must have an excellent negative predictive value to exclude EVs. However, the efficacy of this noninvasive diagnosis is not proven sufficient enough to replace the endoscopy. Further study with large sample size with prospective cohort studies are needed to validate its efficacy.
